Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-10

Clinical Trial Update: Role of Salbutamol in the Management of Transient Tachypnea of the New Born [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the use of salbutamol for the management of Transient tachypnea of the newborn has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Salbutamol (salbutamol)

Snippet

Sponsor: Khyber Teaching Hospital | Conditions: TTN | Phase 1 | Status: COMPLETED